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http://dxObjectives: All lymph node stations but the para-aortic are accessible by a combination of endoscopic ultra-
sound and endobronchial ultrasound.We recently described an echographic-endoscopic technique for the biopsy
of para-aortic (station 6) lymph nodes without traversing the thoracic aorta. This study reviewed our initial ex-
perience with this new technique.
Methods: This first-in-human evaluation of the biopsy of station 6 mediastinal lymph nodes with curvilinear
endoscopic ultrasound without arterial puncture used a retrospective case series design to study 12 consecutive
patients who underwent this new technique. Station 6 lymph nodes were approached with a long fine needle as-
piration approach (6-8 cm) through the proximal esophagus. The needle was passed through the esophagus
into the mediastinum just medial to the left subclavian artery. It was then directed toward the para-aortic
location (6-8 cm trajectory) to reach and enter the para-aortic lymph nodes without piercing the aorta or great
vessels.
Results: Successful cytologic diagnoses of station 6 lymph nodes were obtained in all cases (lymphocytes in all
samples). Nomorbidity resulted from the procedure, nor was any observed at 30 days after the procedure. Patient
anatomy may preclude safe access in certain situations.
Conclusions: Endoscopic ultrasound access of para-aortic (station 6) lymph nodes allows complete, minimally
invasive mediastinal lymph node staging and diagnosis without traversal of the aorta. This technique, the final
piece of the puzzle required for complete staging of the mediastinum with nonsurgical endoscopic techniques, is
reproducible and safe. (J Thorac Cardiovasc Surg 2012;144:787-93)Endoscopic ultrasound (EUS) and endobronchial ultra-
sound (EBUS) with transluminal biopsy of mediastinal
lymph nodes have together revolutionized the diagnosis
and staging of the mediastinum in patients with mediastinal
lymph node metastases. Traditionally, access to mediastinal
lymph nodes has been obtained by surgical mediastino-
scopy, anterior mediastinotomy, video-assisted thoraco-
scopic surgery (VATS), or thoracotomy.1-8 With the
advent of echographic-endoscopic technology, through
both the esophagus and tracheobronchial tree, minimally in-
vasive, transluminal, nonsurgical lymph node aspiration
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The Journal of Thoracic and CaThese techniques are rapidly replacing traditional surgical
methods for lymph node biopsy.
All lymph node stations, except the para-aortic lymph
node station, are directly accessible with a combination of
EUS and EBUS (Table 1).9,10 Because of the anatomic
constraints of the aortic arch, however, both EBUS and
EUS have been thought to be incapable of accessing the
level 6 (para-aortic) lymph node station without traversing
the aorta (Figures 1 and 2). The station 6 nodes sit on the
lateral portion of the aortic arch.11 Transbronchial ultra-
sound–guided biopsy with EBUS would require a needle
path through the left main stem bronchus, through the me-
dial and lateral walls of the aorta, and then into the lymph
nodes. EUS access of these nodes was also thought to be im-
possible, requiring puncture of the pulmonary artery, aorta,
or both to reach the para-aortic location. Although trans-
aortic biopsy of mediastinal lymph nodes and lung masses
has been previously described,12,13 it has a low likelihood
of gaining widespread acceptance because of the theoretic
risks associated with a transaortic puncture.
We have recently described an echographic-endoscopic
technique for the biopsy of para-aortic (station 6) lymph no-
des without traversing the thoracic aorta or pulmonary ar-
tery.14 This is the final frontier in complete minimally
invasive, natural orifice mediastinal lymph node staging.rdiovascular Surgery c Volume 144, Number 4 787
TABLE 1. Endoscopic ultrasound and endobronchial ultrasound
accessibility for mediastinal lymph node stations
LN station Description
Accessible
EBUS EUS
EBUS
and EUS
1 Highest mediastinal Yes No No
2R Right upper paratracheal Yes Difficult Yes
2L Left upper paratracheal Yes Yes Yes
3A Presvascular Yes No No
3P Retrotracheal Yes Yes Yes
4R Right lower paratracheal Yes Difficult Yes
Abbreviations and Acronyms
CT ¼ computed tomography
EBUS ¼ endobronchial ultrasound
EUS ¼ endoscopic ultrasound
VATS ¼ video-assisted thoracoscopic surgery
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and results with this new technique in a series of consecu-
tive patients.4L Left lower paratracheal Yes Yes Yes
5 Subaortic (aortopulmonary
window)
No Yes No
6 Para-aortic No New No
7 Subcarinal Yes Yes Yes
8R, 8L Paraesophageal No Yes No
9R, 9L Pulmonary ligament No Yes No
10R, 10L Hilar Yes No No
11R, 11L Interlobar Yes No No
12R, 12L Lobar Yes No No
Lymph node stations are designated according to the International Association for the
Study of Lung Cancer scheme. EBUS, Endobronchial ultrasound; EUS, endoscopic
ultrasound; LN, lymph node.MATERIALS AND METHODS
This study consists of a retrospective case series. It is a review of the ini-
tial experience with a novel technique consisting of the biopsy of station 6
(para-aortic) mediastinal lymph nodes with curvilinear EUS without arte-
rial puncture. All cases were drawn from a prospectively accrued thoracic
surgery interventional endoscopy research database. The study reports the
cases of 12 consecutive patients who underwent staging with this new
technique.
All patients provided informed consent for echographic-endoscopicme-
diastinal lymph node staging with a combined EBUS-EUS approach before
their procedures. The study was approved by the institutional review board
at the Centre de Recherche du CHUM, University of Montreal. All patients
underwent the procedure with either general anesthesia or local anesthesia
with mild to heavy sedation. Anesthesia choice was based on endoscopist
preference and was subjectively determined on the basis of patient clinical
characteristics and computed tomographic (CT) scan criteria.Most patients
underwent EBUS-EUS procedures under local anesthesia with mild to
moderate sedation.
Because of the technical difficulty with the biopsy of station 6 lymph
nodes and the risks related to the procedure, attempted biopsy of station
6 lymph nodes was only performed in a clinical situation in which there
were either no other lymph node stations that were radiologically suspect
according to CT scan (<1 cm short axis) or according to positron emission
tomography–CT (fludeoxyglucose nonavid) and in which the biopsy of sta-
tion 6 was considered to have the potential to alter the management plan for
the specific patient. Patients with ectatic left subclavian arteries, severe cal-
cification of the aortic arch or left subclavian artery, inability to remain still
during the procedure, lymph nodes too lateral or inferior on the aortic arch,
or lymph nodes deemed by the endoscopist to be too small for safe biopsy
did not have biopsy attempted with the described technique.
The first of these procedures was performed in December 2010, and the
last procedure was performed in September 2011 (10 months). During the
period covered by the study, 395 interventional thoracic endoscopic proce-
dures and 274 combined EBUS-EUS procedures were performed at the
CHUM Endoscopic Tracheobronchial and Oesophageal Center, Division
of Thoracic Surgery, Centre Hospitalier de l’Universite de Montreal.
EUS access for station 6 was deemed necessary and attempted in only
12 of the 274 mediastinal staging procedures (4.4%).
All patients underwent plain film chest radiography after their proce-
dures to rule out mediastinal hematoma, pneumothorax, and hemothorax.
Patients were followed up at 30 days after the procedure by either telephone
interview or outpatient clinic visit.
Technique
Differentiation between stations 5 and 6 was made on the basis of pre-
procedural CT scan images and the real-time EUS imaging during the pro-
cedure. On EUS imaging, however, one is able to identify many more
lymph nodes than on CT scan because of the echogenic characteristics of
most lymph nodes. Any lymph node that was found on EUS to be lateral788 The Journal of Thoracic and Cardiovascular Surgto the aortic arch (para-aortic) was identified as a station 6 lymph node,
whereas any node that lay between the aorta and the left main pulmonary
artery was identified as a station 5 lymph node.
Station 6 lymph nodes are visualized during convex EUS by locating the
aortic arch on the left lateral side of the mediastinum, approximately 1 to 2
cm above the upper edge of the left main stem bronchus, and scanning in
a radial manner while looking through the aortic arch (Figures 3 and 4).
During EUS access of para-aortic (station 6) lymph nodes, lymph nodes
were approached through the proximal esophagus (20-25 cm from the in-
cisors). An EUS fine-needle aspiration needle was passed through the
esophageal wall into the mediastinum immediately medial to the left sub-
clavian artery and then directed toward the para-aortic location. The needle
was passed through the esophagus into the mediastinum immediately next
to the left subclavian artery, 4 to 5 cm distal to its takeoff from the aortic
arch. It was then directed toward the para-aortic location with a 6- to
8-cm trajectory to reach and enter any para-aortic lymph nodeswithout pierc-
ing the aorta or great vessels (Figures 5 and 6). The lymph node was not
visualized when passing the needle out into the mediastinum, and a mental
image of where it is located therefore had to be kept in the endoscopist’s
head as the scope was slowly withdrawn above the aortic arch.
All procedures in this study were performed with a curvilinear EUS
scope (Olympus GF-UC140P-AL5; Olympus Canada Inc, Richmond
Hill, Ontario, Canada; and Aloka Alpha 10 Processor, Hitachi-Aloka
Medical, Tokyo, Japan) and a 22-guage EUS fine-needle aspiration nee-
dle (Cook EchoTip Ultra EUS needle; Cook Medical, Bloomington,
Ind). At minimum, 2 passes per lymph node station were performed.
Cytologic slides as well as a histologic cell block were prepared for anal-
ysis by the surgical team, without on-site cytologic technicians or
cytopathologists.RESULTS
Diagnosis, biopsy result, and echographic lymph node
characteristics are described in Table 2. Successful cyto-
logic diagnoses of station 6 lymph nodes were obtained inery c October 2012
FIGURE 1. Axial computed tomographic scan image demonstrating para-
aortic lymphadenopathy in the station 6 location. Enlarged lymph nodes in
the para-aortic position (station 6) are marked with arrows.
FIGURE 3. Curvilinear endoscopic ultrasound image of a lymph node in
the station 6 position. The station 6 lymph node is marked with an arrow.
PA, Left pulmonary artery.
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There were no insufficient samples. Two patients consid-
ered eligible for EUS biopsy of station 6 lymph nodes ac-
cording to clinical and radiologic criteria were excluded
from the series because of anatomic constraints (ectatic
left subclavian artery, heavily calcified aorta).FIGURE 2. Axial computed tomographic scan image demonstrating para-
aortic lymph nodes in the station 6 location. Lymph nodes in the para-aortic
position (station 6) are marked with arrows.
The Journal of Thoracic and CaOne patient in this study (patient 11; Table 2) underwent
surgical confirmation of the station 6 lymph node. This pa-
tient had a large (8 3 8 3 6 cm) left upper lobe and hilar
adenocarcinoma. She underwent complete minimally inva-
sive mediastinal lymph node staging with a combined
EBUS-EUS procedure. All lymph nodes biopsied (11L,
4R, 4L, 5, and 7), including the station 6 lymph node,
yielded negative results on cytologic analysis. The station
6 lymph node was measured by EUS to be 1.0 3 0.9 cm;
it had low-echogenicity, nonsharp borders and was oval in
shape. The patient subsequently underwent a left VATS
pneumonectomy on a separate occasion. Final pathologic
study of the thoracoscopic mediastinal lymph node dissec-
tion at that time confirmed that all lymph nodes, including
the station 6 lymph nodes, were free of malignancy.FIGURE 4. Curvilinear endoscopic ultrasound image of an enlarged
lymph node (LN) in the station 6 position. The station 6 lymph node is
labeled LN #6. L, Left; PA, pulmonary artery.
rdiovascular Surgery c Volume 144, Number 4 789
FIGURE 5. Curvilinear endoscopic ultrasound image of a lymph node
(LN) in the station 6 position during fine-needle aspiration biopsy. The
needle is marked with an arrow. L, Left.
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mation of station 6 lymph node status. This is because in
this cohort either station 6 lymph nodes were positive and
the patients were ineligible for surgical resection or neoad-
juvant therapy followed by surgical resection, or the nodes
were negative but the patients had extrathoracic malignancy
(colon cancer or anal cancer).
No morbidity resulted from the procedure. No occur-
rences of pneumothorax, pneumomediastinum, hemothorax,
or mediastinal hematoma were observed on postprocedural
chest radiographs. No morbidity related to the EUS
procedure was observed in any patient at 30-day follow-up.FIGURE 6. Schematic drawing depicting the technique of endoscopic ultrason
approached by a long approach through the proximal esophagus. The needle is pa
to 5 cm distal to its takeoff from the aortic arch and is then turned inferiorly and
790 The Journal of Thoracic and Cardiovascular SurgDISCUSSION
Lymph nodes within the mediastinum have traditionally
been staged with surgical lymph node biopsy by means of
cervical mediastinoscopy, anterior mediastinotomy and
mediastinoscopy, thoracoscopy, or thoracotomy.1-8 EUS
and EBUS as minimally invasive modalities for staging
the mediastinum without surgery are quickly replacing
traditional surgical techniques.9,10 Before the introduction
of the described technique, the combination of EBUS and
EUS allowed almost complete, minimally invasive,
endoscopic mediastinal lymph node staging and diagnosis
for all mediastinal lymph node stations11,15 except the
para-aortic lymph node station (station 6).16,17 Combined
EBUS-EUS allows a ‘‘complete medical mediastino-
scopy,’’18 which allows access not only to all mediastinal
lymph node stations but also to the bilateral adrenal glands,
the celiac axis lymph nodes, and the liver. EBUS and EUS
are complementary with one another19,20 and can even
complement surgical21,22 and radiologic23 staging. Table 1
outlines techniques for minimally invasive access to medi-
astinal lymph nodes by EBUS and EUS.
This report describes the successful application of a new
technique for access to the para-aortic lymph node stations
without the added risk of transaortic puncture. The tech-
nique is technically demanding and requires not only a great
deal of precision but also the cooperation of the patient in
using deep sedation or general anesthesia.
Although no morbidity was observed in this series,
potential dangers to the procedure are related to the long
transmediastinal trajectory, with risks of bleeding, pneumo-
thorax, lung laceration, esophageal laceration with fistula
formation, and mediastinal abscess. Furthermore, theographic access to para-aortic mediastinal lymph nodes. Lymph nodes are
ssed immediately medial to the left subclavian artery (A). It then is passed 4
laterally once past the artery (B) to approach the station 6 lymph nodes (C).
ery c October 2012
TABLE 2. Endoscopic ultrasound station 6 lymph node biopsy: Patient characteristics
Patient Diagnosis LNs in position 6 Size of LN biopsied (cm) LN echogenicity LN borders LN shape EUS LN 6 result
1 Esophageal cancer 1 1.2 3 0.9 Medium Hazy Polypoid Positive
2 Cervical cancer 1 1.6 3 0.9 Medium Sharp Triangular Positive
3 NSCLC 1 2.1 3 1.6 Low Sharp Round Positive
4 SCLC 1 2.6 3 2.1 High Sharp Round Positive
5 NSCLC 1 0.8 3 0.9 High Sharp Round Positive
6 Breast cancer 1 1.9 3 1.4 High Hazy Polypoid Positive
7 NSCLC 2 1.7 3 1.6 Low Sharp Round Positive
8 Colon cancer 1 1.1 3 1.1 Medium Hazy Polypoid Negative
9 Anal cancer 3 1.4 3 1.0 Medium Sharp Round Negative
10 NSCLC 1 3.7 3 2.6 High Sharp Round Positive
11 NSCLC 1 1.0 3 0.9 Low Hazy Oval Negative
12 NSCLC 1 1.7 3 1.3 Medium Hazy Round Negative
EUS, Endoscopic ultrasound; LN, lymph node; NSCLC, non–small cell lung cancer; SCLC, small cell lung cancer.
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ciated with risks of arterial puncture, laceration, and pseu-
doaneurysm formation.
Patient anatomy may preclude this procedure. Anatomic
factors that may make this procedure difficult or impossible
include enlarged diameter of the transverse or ascending
aortic arch, early takeoff of the left subclavian artery, aneu-
rysmal dilation of the left subclavian artery, heavily calci-
fied aorta, and lymph node location very caudad on the
descending aortic arch. There were 274 patients who under-
went EBUS-EUS staging during the study period. Twelve
patients had EUS biopsy of station 6, and in 2 patients
EUS biopsy was precluded by patient anatomy. One patient
had an ectatic and enlarged aorta, precluding access to the
station 6 lymph node. The other patient had heavy, irregular
calcification on the aortic arch and left subclavian artery,
and it was therefore considered too dangerous to pass the
needle into the mediastinum without a clear path to the sta-
tion 6 lymph node.
With EUS access, other mediastinal lymph nodes (aside
from station 6) can successfully be biopsied even when as
small as 2 mm. EUS access of station 6 is more complicated
and difficult because of the needle puncture of the lymph
node very far from the esophageal puncture site and the
movement of the aortic arch. The smallest lymph node biop-
sied in the current series was 0.8 3 0.9 cm. Smaller lymph
nodes may be accessible; as the size of the lymph node de-
creases, however, the difficulty of the procedure increases.
The strengths of this study include the prospective nature
of the data collection and complete follow-up in the entire
cohort. Limitations of this study include the small number
of patients and inherent selection bias. Two patients eligible
for EUS biopsy of station 6 lymph nodes according to clin-
ical and radiologic criteria were excluded from the series
because of anatomic constraints. A further limitation in-
cludes the potential lack of generalizability as a result of
the high volume EBUS-EUS practice of the thoracic endo-
scopists performing the procedures in this series.The Journal of Thoracic and CaIn centers where EUS is available, this approach may be-
come the first approach attempted for the biopsy of station 6
lymph nodes, reserving VATS or anterior mediastinotomy
as second-line approaches. The EUS approach does not re-
quire general anesthesia in most cases; in addition, it is not
associated with postprocedural pain and therefore does not
necessitate analgesic medication on discharge. Further-
more, there are no wounds, thus obviating the risk of
wound-related complications. The procedure can also be
performed on an outpatient basis.
EUS access of para-aortic (station 6) lymph nodes allows
complete, minimally invasive, endoscopic mediastinal
lymph node staging and diagnosis without traversal of the
aorta. By using a combined EBUS-EUS procedure, the tho-
racic endoscopist is capable of assessing all lymph node sta-
tions. The use of EUS to biopsy station 6 lymph nodes is
safe and reliable for appropriately selected patients.References
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Dr Chumy Nwogu (Buffalo, NY). This was a very fascinating
presentation. I really enjoyed it. I have a question about how you
were able to maneuver the needle after you got it out lateral to
the arch. That seems technically difficult.
My second question is, when you are imaging with this partic-
ular linear EUS scope, it seems to me—and the illustration I
think was very helpful—that you are higher than or proximal
to the nodes. So when you are imaging, how well do you
see these nodes that are further downstream from where your
probe is?
Dr Liberman. Thank you. These are very good questions. I
will start with the second question. We completely stage the me-
diastinum on EUS after our EBUS procedure, and we start in the
belly moving upward. We evaluate the celiac access, the liver,
and the adrenal gland, and we come back for the inferior ligament
nodes. Then, when we get to the station 5 and then the station 6
nodes, we are looking at the node through the aorta, as I showed
on the picture. Once we have seen the node, we have measured it,
and we feel that it is accessible, then we pull the scope back about
4 to 5 cm above the aortic arch. At that time, we no longer see
that node.
Obviously in the images I showed you, those are the bigger no-
des, because it was easier to demonstrate in the presentation;792 The Journal of Thoracic and Cardiovascular Surghowever, a lot of the nodes in this study were smaller than that,
and they would be even harder to see in the high mediastinum.
And going along the same lines to answer your first question,
EUS, unlike EBUS, has the advantage of having a scope not
only with 2 wheels but also with a tip deflector, where the needle
itself is being bent without the scope being bent. You have a very
long needle, as long as 8 cm. You can pass that needle out into the
mediastinum.
The way we do it is that once we have decided where that node
is, we slowly pull the scope back. It depends on the patient anat-
omy, but it is usually about 20 to 25 cm from the incisors. And
then we pass the needle out into the mediastinum. The mediastinal
tissues, being rigid or somewhat rigid in the fat of the mediasti-
num, hold the needle in place, and as we advance the needle, we
turn the big wheel of the scope back and we use the tip deflector
to turn the needle forward, thus allowing us to get around the aorta.
The key is that once you have passed out into the mediastinum
just medial to the left subclavian artery, the main risk is gone. The
risk then only becomes the potential for puncture of the pleura and
possible pneumothorax, which we have not seen. But getting out
into the mediastinum outside of the vessels is the key, and once
you are out there, you have much more play and it is much easier
to do. Again, as you said, it is technically a more difficult node to
biopsy than is a station 7 or 4 or something else.
Dr Nwogu. You are implying that when you actually pass the
needle then you are not visualizing the node at that particular mo-
ment. Is that what you are saying?
Dr Liberman. Correct.
Dr Nwogu. You are using the mental image that you have from
the earlier visualization?
Dr Liberman. Correct.
Dr Nwogu. That lack of direct visualization seems to increase
the risk of the procedure a little bit.
Dr Liberman. Yes, it is a technically difficult thing to do. The
station 6 node is not a node that needs to be biopsied in most sit-
uations, but in the cases that it needs to be done, you are avoiding
a Chamberlain or a left VATS procedure. This endoscopic ap-
proach is done as an outpatient procedure. There is extremely
low risk. We have not seen any complications in our series.
And if you should get a pneumothorax, first of all, you would
see it right away on EUS; it would be easy to see. We have not
had it happen yet in this type of procedure. And it really would
not be the end of the world. Most pneumothoraces caused by
EUS do not need to be treated.
Dr David J. Sugarbaker (Boston, Mass). This is a very inter-
esting presentation, and I have 2 questions. The first is, what would
you say the learning curve is on what appears to be, as you said,
a more complex, technically demanding procedure?
Dr Liberman. Thank you. This is a very good question. This is
not the first node that you want to biopsy when you are starting
your EUS practice. We are doing a high volume, about 600 EUS
cases a year for multiple years, and we have a large experience
with EBUS. But I think that it is doable. A thoracic surgeon will
be able to do this technique a lot better and with a lot more confi-
dence and safety than, for example a gastroenterologist. I think that
the anatomy is well known to this group, and the ease or the lack of
stress in that mediastinal area for people in this room will be a lot
less than for a nonthoracic surgeon.ery c October 2012
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able, and it is learnable. It is certainly not more difficult than
a VATS lobectomy!
Dr Sugarbaker. The other question I had is just in looking at
the positioning of the scope, have you ever thought about placing
an ultrasound bronchoscope in along with the esophagoscope so
that you could position that just across from the node and at that
point actually visualize? I think many of us are a little concerned
about passing the needle without seeing the lymph node. Have you
ever thought about doing something like that?
Dr Liberman. It is a very good question. We have done that in
other situations with multiple scopes, EBUS, EUS, in the esopha-
gus during other procedures, especially in the animal laboratory. In
this situation we have not used it, because we have not found that it
would be important in our practice. But it definitely is something
that would be an option for people who would be scared to find out
where that node is.
But do not forget, when you are doing this procedure, it is not
blind. You are following the left subclavian artery; you do see it,
and sometimes with a bigger node you will see it at the same
time as you are passing out into the mediastinum. Again, youThe Journal of Thoracic and Cahave just pulled back 1 or 2 cm; in general, you are watching the
node, it is 2 seconds later, and you see the artery, which you
know enters the aorta. The risk of the procedure I think is more
the arterial puncture and the potential pseudoaneurysm formation
or mediastinal bleeding. If you get out into the mediastinum and
then you cannot find a node, just pull your needle back and do it
again. It is a very small hole that you are making in the esophagus.
Dr Sugarbaker. I will just correct you that thoracic surgeons
are never scared—but they may be concerned.
Dr Liberman. Thank you.
Dr Charles R. Bridges (Charlotte, NC). Given that in your ab-
stract you presented only 12 patients, do you think it is a little pre-
mature to declare this procedure to be safe and reproducible?
Dr Liberman. That is a very good point. This is a very early
experience with a new technique. I know that there have been peo-
ple who have trained with us who have gone out and tried to do this
technique, somewith success and somewithout success. At least in
my experience, and from what I have heard from others, there has
been no associated morbidity, but it is too early to say, and at 12
cases I think you make a very good point. We cannot say that
this is safe in the long term.rdiovascular Surgery c Volume 144, Number 4 793
